PropThink: ARIA Bounces After Morning Downgrade

[ACN Newswire] – By Jake KingShares of ARIAD Pharmaceuticals (NASDAQ:ARIA) were under pressure Tuesday following a downgrade from Oppenheimer, which lowered ARIA from Outperform to Perform with a $23 price target. ARIA … more

View todays social media effects on ARIA

View the latest stocks trending across Twitter. Click to view dashboard